Through
1/1
If Black patients were admitted to the same hospitals that serve a majority of white patients, Penn Medicine researchers show their risk of death would drop by 10%.
The Rapid Response Grants for COVID-19 research projects have produced important new insights relevant to current pandemic response, as well as preparations for future infectious disease emergencies.
A challenging yet successful year—Penn’s exceptional community of dedicated students, faculty, and staff overcame the world’s most significant obstacles to flourish, from outreach locally through volunteerism, to helping the world globally with mRNA technology. The 2021 academic year highlighted the best of Penn.
The drug diABZI—which activates the body’s innate immune response—was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2 and likely other coronaviruses.
T cells can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19.
The low-cost biosensor test developed by Penn Medicine could extend COVID-19 testing with 90% accuracy to remote and disadvantaged areas.
Tests of a new antiviral that aims to prevent the deadly Marburg virus from spreading in the body show promise, according to a study led by School of Veterinary Medicine researchers.
Key breakthroughs leading to the powerful mRNA vaccines against COVID-19 were forged at Penn, and the COVID-19 vaccines may only be the beginning of its impact on 21st-century medicine.
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, therefore only a single dose may be needed to produce a sufficient antibody response, according to new research from the Penn Institute of Immunology.
In a proof-of-concept study led by the School of Veterinary Medicine, dogs identified positive samples with 96% accuracy.
Penn is lauded for its research and development efforts, including the modified mRNA technique that was commercialized into a COVID vaccine and won its researchers a Nobel Prize last year.
FULL STORY →
Ken Cadwell of the Perelman School of Medicine studies how COVID affects the gut and explains you will feel the illness in other parts of your body and not just your lungs.
FULL STORY →
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →